Today, IBM announced its data-driven tool, IBM Study Advance that optimizes clinical trial protocol design by providing access to real-world patient population data, a collaborative workplace and standardizing protocol template guidance.
Date : February 18, 2020 at 05:28PM
Tag(s) : #eSANTE ENG
